A cavity-reduced prefusion RSV F bivalent vaccine elicits durable and protective immunity
Open Access
- 29 August 2026
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 18 (10) , 3979-4000
Abstract
Respiratory syncytial virus (RSV) remains a major cause of severe respiratory disease, and stabilization of the prefusion (preF) conformation of the F glycoprotein is central for vaccine development. Here, we report a structure-guided engineering strategy that enhances preF stability by reducing the hydrophobic cavity within the trimeric F protein. Targeted modifications at metastability-associated sites generated RVF-88, a disulfide-free stabilized preF immunogen that preserves key neutralizing epitopes, including antigenic site Ø, while exhibiting improved structural integrity and long-term storage stability. Formulated as an unadjuvanted bivalent vaccine, RVF-88 elicited potent neutralizing antibody responses and durable immune protection lasting up to 5 months in mice. Vaccination also protected both mice and cotton rats against RSV challenge. Structural analyses confirmed the intended cavity-reduction design, revealing a reduced apical hydrophobic cavity volume and surface area while maintaining the prefusion architecture. Together, these findings establish hydrophobic cavity reduction as a rational strategy for stabilizing prefusion RSV F and provide a promising next-generation vaccine candidate with improved stability and immunogenicity for further clinical development.Keywords
Funding Information
- Guangzhou National Laboratory (YW-JCZD0105)
- Guangzhou National Laboratory (GZNL2025C01020)
- Guangzhou National Laboratory (GZNL2023A01007)
- State Key Laboratory of Respiratory Disease (SKLRD-Z-202512)
- Basic and Applied Basic Research Foundation of Guangdong Province (2025A1515011053)
- Guangzhou Municipal Science and Technology Program key projects (2023QN10Y428)
- National Natural Science Foundation of China (32100142)
- State Key Laboratory of Medicinal Chemical Biology (2025010)
- State Key Laboratory of Medicinal Chemical Biology (2025013)
This publication has 52 references indexed in Scilit:
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial VirusScience, 2013
- Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing AntibodyScience, 2013
- Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing EpitopesJournal of Virology, 2011
- The cotton rat model of respiratory viral infectionsBiologicals, 2009
- Differential Role of Gamma Interferon in Inhibiting Pulmonary Eosinophilia and Exacerbating Systemic Disease in Fusion Protein-Immunized Mice Undergoing Challenge Infection with Respiratory Syncytial VirusJournal of Virology, 2008
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Small Molecules VP-14637 and JNJ-2408068 Inhibit Respiratory Syncytial Virus Fusion by Similar MechanismsAntimicrobial Agents and Chemotherapy, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Size-Distribution Analysis of Proteins by Analytical Ultracentrifugation: Strategies and Application to Model SystemsBiophysical Journal, 2002
- Stabilization of short collagen-like triple helices by protein engineeringJournal of Molecular Biology, 2001